Sample no. | Diagnosis | FIGO stage | Age | Pre-operative CA125 | Survival |
---|---|---|---|---|---|
Normal | Â | Â | Â | Â | Â |
1 | Normal ovarian epithelium | - | NA | - | - |
2 | Normal ovarian epithelium | - | 61 | - | - |
3 | Normal ovarian epithelium | - | 69 | - | - |
4 | Normal ovarian epithelium | - | 65 | - | - |
5 | Normal ovarian epithelium | - | 62 | - | - |
6 | Normal ovarian epithelium | - | NA | - | - |
Borderline | Â | Â | Â | Â | Â |
1 | Serous cystadenocarcinoma | Ib | 50 | 12 | 4Â years 10Â months ALC |
2 | Serous cystadenocarcinoma | Ic | 31 | 117 | 4Â years 9Â monthsa |
3 | Serous cystadenoma | Ia | 60 | 1237 | 5Â years ALC |
4 | Serous cystadenoma | Ic | 32 | 34 | 4Â years 8Â monthsa |
5 | Papillary serous cystadenocarcinoma | Ia | 47 | NA | 5Â years 8Â months ALC |
Grade 2 | Â | Â | Â | Â | Â |
1 | Papillary serous cystadenocarcinoma | IIIc | 71 | NA | 8Â months ALC |
2 | Papillary serous cystadenocarcinoma | IIIc | 43 | 428 | 3Â years 7Â months until death |
3 | Papillary serous cystadenocarcinoma | IIIc | 52 | 309 | 10Â months ALC |
4 | Papillary serous cystadenocarcinoma | IV | 58 | 3187 | 6Â years 1Â months ALC |
5 | Papillary serous cystadenocarcinoma | IIIc | 41 | NA | 8Â years 8Â monthsa |
6 | Serous cystadenoma NOS | IIIc | 49 | 463 | 2Â years 7Â monthsa |
7 | Serous cystadenoma NOS | IIIa | 64 | 1404 | 7Â months ALC |
Grade 3 | Â | Â | Â | Â | Â |
1 | Papillary serous cystadenoma | IIIc | 75 | 1443 | 4Â yrsa |
2 | Papillary serous cystadenocarcinoma | IIc | 67 | 24 | 2Â months ALC |
3 | Serous cystadenocarcinoma NOS | IIIc | 55 | 3025 | 2Â years 5Â months until death |
4 | Serous cystadenocarcinoma NOS | IIIc | 59 | 4224 | 1Â year 4Â months until death |
5 | Serous cystadenocarcinoma NOS | IIIc | 76 | 130 | 3Â years 6Â monthsa |
6 | Serous cystadenocarcinoma NOS | IIc | 60 | 107 | 3Â years 6Â monthsa |
7 | Serous cystadenocarcinoma NOS | IIIc | 42 | 264 | 10Â months until death |
8 | Serous cystadenocarcinoma NOS | IIIc | 58 | 490 | 2Â years 8Â monthsa |